Alexion Pharmaceuticals, Inc. · 1 day ago
HPP-Patient Marketing Intern (Undergraduate)
Boston, Massachusetts, United States of America
Internship
Onsite
Intern
$31/hr - $32.50/hr
Start in 2026 SummerAlexion Pharmaceuticals, Inc. is seeking an undergraduate intern for their Patient Marketing team in Boston, MA. The role involves providing operational support for patient marketing projects and assisting in the development of patient education materials and social media content.
BiotechnologyHealth CareMedicalTherapeutics
No H1B
Responsibilities
Provide operational support for patient marketing projects, coordinating deliverables, timelines, and the promotional review process
Supporting the creation of patient education materials and their rollout to the internal and external HPP community in July
Assisting with development of slide decks, agendas, and follow-up communications for internal stakeholders
Supporting the development of social media content for the HPP Patient Marketing Team’s five social media channels (posted quarterly) from content development and PRC review to metrics evaluation
Qualification
Required
Sophomore and Junior students majoring in Communications, Biology, Chemistry, Biochemistry, Business, or a related field
Candidates must have an expected graduation date after August 2026
Expressed interest in pharmaceutical industry
Basic project management skills such as managing multiple timelines and coordinating deliverables are a plus
Social media skills are a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to the Seaport neighborhood in Boston, MA site 3 days per week
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Founded in 1992
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase